LUMI-PN EYES | 1×1.5ml per pack | Polynucleotide (PDRN)
LUMI-PN EYES | 1×1.5ml per pack | Polynucleotide (PDRN)
Couldn't load pickup availability
Introducing LUMI-PN Eyes, an advanced Polynucleotide (PN) treatment specifically designed to rejuvenate the delicate under-eye area.
Formulated with 20mg/ml of ultra-pure Polynucleotide (PDRN), this innovative treatment stimulates skin tissue regeneration, boosts collagen synthesis, and effectively reduces the appearance of dark circles. Each industry-leading 1.5ml syringe contains a total of 30mg of PDRN, working to brighten and even out skin tone for a more radiant complexion.
When used with microneedling (poly-needling), LUMI-PN Eyes delivers deep skin rejuvenation. This process enhances hydration, brightens skin tone, and fortifies the skin's natural barrier. Its anti-inflammatory properties ensure minimal downtime while effectively smoothing fine lines and improving texture. The result is a healthier, revitalised appearance, making it an ideal solution for the sensitive under-eye region.
Learn more about the benefits of polynucleotides.
Key Features:
- Contains 30mg of ultra-pure PDRN per 1.5ml syringe.
- Targets dark circles, promotes tissue repair, and creates smoother skin.
- Brightens and evens skin tone for a radiant look.
- Suitable for microneedling treatments.
Box Contents:
- 1 x 1.5ml pre-filled syringe
IGO Aesthetics
Verified Seller on Bidnamic Store
Free Shipping
Free Shipping
Shipping Overview:
- Daily Cut-Off: Orders placed before 16:00 GMT are prepared the same working day
- Preparation Time: 0–1 working days (Monday to Friday)
- Delivery Window: 5–10 working days after dispatch (Monday to Friday)
- UK Delivery: Free shipping is provided on all orders within the United Kingdom
For more information, click here
30-Days Return
30-Days Return
Essential Details:
- Return Window: 30 days from the date of delivery
- Restocking Fees: None
- Refund Timeline: Usually within 7 business days
- Return Shipping: Customers cover the cost of sending items back
For more information, click here